Literature DB >> 20639879

Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis.

Gideon M Hirschfield1, Xiangdong Liu, Younghun Han, Ivan P Gorlov, Yan Lu, Chun Xu, Yue Lu, Wei Chen, Brian D Juran, Catalina Coltescu, Andrew L Mason, Piotr Milkiewicz, Robert P Myers, Joseph A Odin, Velimir A Luketic, Danute Speiciene, Catherine Vincent, Cynthia Levy, Peter K Gregersen, Jinyi Zhang, E Jenny Heathcote, Konstantinos N Lazaridis, Christopher I Amos, Katherine A Siminovitch.   

Abstract

We genotyped individuals with primary biliary cirrhosis and unaffected controls for suggestive risk loci (genome-wide association P < 1 x 10(-4)) identified in a previous genome-wide association study. Combined analysis of the genome-wide association and replication datasets identified IRF5-TNPO3 (combined P = 8.66 x 10(-13)), 17q12-21 (combined P = 3.50 x 10(-13)) and MMEL1 (combined P = 3.15 x 10(-8)) as new primary biliary cirrhosis susceptibility loci. Fine-mapping studies showed that a single variant accounts for the IRF5-TNPO3 association. As these loci are implicated in other autoimmune conditions, these findings confirm genetic overlap among such diseases.

Entities:  

Mesh:

Year:  2010        PMID: 20639879      PMCID: PMC2929126          DOI: 10.1038/ng.631

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  15 in total

1.  The New York Cancer Project: rationale, organization, design, and baseline characteristics.

Authors:  Maria K Mitchell; Peter K Gregersen; Stephen Johnson; Ramon Parsons; David Vlahov
Journal:  J Urban Health       Date:  2004-06       Impact factor: 3.671

2.  Effect of 17q21 variants and smoking exposure in early-onset asthma.

Authors:  Emmanuelle Bouzigon; Eve Corda; Hugues Aschard; Marie-Hélène Dizier; Anne Boland; Jean Bousquet; Nicolas Chateigner; Frédéric Gormand; Jocelyne Just; Nicole Le Moual; Pierre Scheinmann; Valérie Siroux; Daniel Vervloet; Diana Zelenika; Isabelle Pin; Francine Kauffmann; Mark Lathrop; Florence Demenais
Journal:  N Engl J Med       Date:  2008-10-15       Impact factor: 91.245

3.  Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease.

Authors:  Jeffrey C Barrett; Sarah Hansoul; Dan L Nicolae; Judy H Cho; Richard H Duerr; John D Rioux; Steven R Brant; Mark S Silverberg; Kent D Taylor; M Michael Barmada; Alain Bitton; Themistocles Dassopoulos; Lisa Wu Datta; Todd Green; Anne M Griffiths; Emily O Kistner; Michael T Murtha; Miguel D Regueiro; Jerome I Rotter; L Philip Schumm; A Hillary Steinhart; Stephan R Targan; Ramnik J Xavier; Cécile Libioulle; Cynthia Sandor; Mark Lathrop; Jacques Belaiche; Olivier Dewit; Ivo Gut; Simon Heath; Debby Laukens; Myriam Mni; Paul Rutgeerts; André Van Gossum; Diana Zelenika; Denis Franchimont; Jean-Pierre Hugot; Martine de Vos; Severine Vermeire; Edouard Louis; Lon R Cardon; Carl A Anderson; Hazel Drummond; Elaine Nimmo; Tariq Ahmad; Natalie J Prescott; Clive M Onnie; Sheila A Fisher; Jonathan Marchini; Jilur Ghori; Suzannah Bumpstead; Rhian Gwilliam; Mark Tremelling; Panos Deloukas; John Mansfield; Derek Jewell; Jack Satsangi; Christopher G Mathew; Miles Parkes; Michel Georges; Mark J Daly
Journal:  Nat Genet       Date:  2008-06-29       Impact factor: 38.330

Review 4.  Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis: diagnostic and prognostic value.

Authors:  Luigi Muratori; Alessandro Granito; Paolo Muratori; Georgios Pappas; Francesco B Bianchi
Journal:  Clin Liver Dis       Date:  2008-05       Impact factor: 6.126

5.  Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus.

Authors:  Snaevar Sigurdsson; Harald H H Göring; Gudlaug Kristjansdottir; Lili Milani; Gunnel Nordmark; Johanna K Sandling; Maija-Leena Eloranta; Di Feng; Niquiche Sangster-Guity; Iva Gunnarsson; Elisabet Svenungsson; Gunnar Sturfelt; Andreas Jönsen; Lennart Truedsson; Betsy J Barnes; Gunnar Alm; Lars Rönnblom; Ann-Christine Syvänen
Journal:  Hum Mol Genet       Date:  2007-12-06       Impact factor: 6.150

6.  Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.

Authors:  O Snir; M Widhe; C von Spee; J Lindberg; L Padyukov; K Lundberg; A Engström; P J Venables; J Lundeberg; R Holmdahl; L Klareskog; V Malmström
Journal:  Ann Rheum Dis       Date:  2008-07-17       Impact factor: 19.103

7.  Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis.

Authors:  P Dieudé; M Guedj; J Wipff; J Avouac; I Fajardy; E Diot; B Granel; J Sibilia; J Cabane; L Mouthon; J L Cracowski; P H Carpentier; E Hachulla; O Meyer; A Kahan; C Boileau; Y Allanore
Journal:  Arthritis Rheum       Date:  2009-01

8.  Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus.

Authors:  Robert R Graham; Chieko Kyogoku; Snaevar Sigurdsson; Irina A Vlasova; Leela R L Davies; Emily C Baechler; Robert M Plenge; Thearith Koeuth; Ward A Ortmann; Geoffrey Hom; Jason W Bauer; Clarence Gillett; Noel Burtt; Deborah S Cunninghame Graham; Robert Onofrio; Michelle Petri; Iva Gunnarsson; Elisabet Svenungsson; Lars Rönnblom; Gunnel Nordmark; Peter K Gregersen; Kathy Moser; Patrick M Gaffney; Lindsey A Criswell; Timothy J Vyse; Ann-Christine Syvänen; Paul R Bohjanen; Mark J Daly; Timothy W Behrens; David Altshuler
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-05       Impact factor: 11.205

9.  Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes.

Authors:  Jeffrey C Barrett; David G Clayton; Patrick Concannon; Beena Akolkar; Jason D Cooper; Henry A Erlich; Cécile Julier; Grant Morahan; Jørn Nerup; Concepcion Nierras; Vincent Plagnol; Flemming Pociot; Helen Schuilenburg; Deborah J Smyth; Helen Stevens; John A Todd; Neil M Walker; Stephen S Rich
Journal:  Nat Genet       Date:  2009-05-10       Impact factor: 38.330

10.  Common variants at CD40 and other loci confer risk of rheumatoid arthritis.

Authors:  Soumya Raychaudhuri; Elaine F Remmers; Annette T Lee; Rachel Hackett; Candace Guiducci; Noël P Burtt; Lauren Gianniny; Benjamin D Korman; Leonid Padyukov; Fina A S Kurreeman; Monica Chang; Joseph J Catanese; Bo Ding; Sandra Wong; Annette H M van der Helm-van Mil; Benjamin M Neale; Jonathan Coblyn; Jing Cui; Paul P Tak; Gert Jan Wolbink; J Bart A Crusius; Irene E van der Horst-Bruinsma; Lindsey A Criswell; Christopher I Amos; Michael F Seldin; Daniel L Kastner; Kristin G Ardlie; Lars Alfredsson; Karen H Costenbader; David Altshuler; Tom W J Huizinga; Nancy A Shadick; Michael E Weinblatt; Niek de Vries; Jane Worthington; Mark Seielstad; Rene E M Toes; Elizabeth W Karlson; Ann B Begovich; Lars Klareskog; Peter K Gregersen; Mark J Daly; Robert M Plenge
Journal:  Nat Genet       Date:  2008-09-14       Impact factor: 38.330

View more
  97 in total

1.  Involvement of commensal bacteria may lead to dysregulated inflammatory and autoimmune responses in a mouse model for chronic nonsuppurative destructive cholangitis.

Authors:  Ikuko Haruta; Ken Kikuchi; Minoru Nakamura; Katsuhiko Hirota; Hidehito Kato; Hiroshi Miyakawa; Noriyuki Shibata; Yoichiro Miyake; Etsuko Hashimoto; Keiko Shiratori; Junji Yagi
Journal:  J Clin Immunol       Date:  2012-06-03       Impact factor: 8.317

2.  A polymorphism in the integrin αV subunit gene affects the progression of primary biliary cirrhosis in Japanese patients.

Authors:  Tatsuo Inamine; Minoru Nakamura; Ayumi Kawauchi; Yayoi Shirakawa; Hisae Hashiguchi; Yoshihiro Aiba; Akinobu Taketomi; Ken Shirabe; Makoto Nakamuta; Shigeki Hayashi; Takeo Saoshiro; Atsumasa Komori; Hiroshi Yatsuhashi; Shinji Kondo; Katsuhisa Omagari; Yoshihiko Maehara; Hiromi Ishibashi; Kazuhiro Tsukamoto
Journal:  J Gastroenterol       Date:  2010-12-01       Impact factor: 7.527

Review 3.  Primary biliary cirrhosis: From bench to bedside.

Authors:  Elias Kouroumalis; George Notas
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-08-06

Review 4.  Gasdermins: Effectors of Pyroptosis.

Authors:  Stephen B Kovacs; Edward A Miao
Journal:  Trends Cell Biol       Date:  2017-06-12       Impact factor: 20.808

Review 5.  Novel therapeutic targets in primary biliary cirrhosis.

Authors:  Jessica K Dyson; Gideon M Hirschfield; David H Adams; Ulrich Beuers; Derek A Mann; Keith D Lindor; David E J Jones
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-02-03       Impact factor: 46.802

Review 6.  Cutting-edge issues in primary biliary cirrhosis.

Authors:  Marco Folci; Francesca Meda; M Eric Gershwin; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

Review 7.  Primary biliary cirrhosis: Clinical and laboratory criteria for its diagnosis.

Authors:  Vasiliy Ivanovich Reshetnyak
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

8.  Etiopathogenesis of primary biliary cirrhosis: an overview of recent developments.

Authors:  Palak J Trivedi; Sue Cullen
Journal:  Hepatol Int       Date:  2012-03-20       Impact factor: 6.047

Review 9.  The genetics of complex cholestatic disorders.

Authors:  Gideon M Hirschfield; Roger W Chapman; Tom H Karlsen; Frank Lammert; Konstantinos N Lazaridis; Andrew L Mason
Journal:  Gastroenterology       Date:  2013-04-10       Impact factor: 22.682

10.  Genetic polymorphisms of OCT-1 confer susceptibility to severe progression of primary biliary cirrhosis in Japanese patients.

Authors:  Yuki Ohishi; Makoto Nakamuta; Naoko Ishikawa; Ohki Saitoh; Hitomi Nakamura; Yoshihiro Aiba; Atsumasa Komori; Kiyoshi Migita; Hiroshi Yatsuhashi; Nobuyoshi Fukushima; Motoyuki Kohjima; Tsuyoshi Yoshimoto; Kunitaka Fukuizumi; Makoto Ishibashi; Takashi Nishino; Ken Shirabe; Akinobu Taketomi; Yoshihiko Maehara; Hiromi Ishibashi; Minoru Nakamura
Journal:  J Gastroenterol       Date:  2013-04-24       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.